UBS Group
IPCI

UBS Group’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

UBS Group’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,339
Closed -$10K – 8500
2018
Q2 		$10K Buy
+2,339
New +$10.6K ﹤0.01% 7168
2018
Q1 		– Sell
-862
Closed -$7K – 8414
2017
Q4 		$7K Buy
+862
New +$7.83K ﹤0.01% 7272
2017
Q2 		– Sell
-202
Closed -$5K – 8221
2017
Q1 		$5K Sell
202
-483
-71% -$12.4K ﹤0.01% 7029
2016
Q4 		$19K Buy
+685
New +$19.1K ﹤0.01% 6558
2015
Q4 		– Sell
-74
Closed -$1K – 8721
2015
Q3 		$1K Buy
+74
New +$1.95K ﹤0.01% 8279
2015
Q1 		– Sell
-10
Closed – – 9716
2014
Q4 		$0 Buy
+10
New +$270 ﹤0.01% 9713

Other funds holding IPCI

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return